The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?
Chapman
Paul
P
Ben Franklin House, Suite 314, 834 Chestnut St, Philadelphia, PA 19107, USA.
Cranmer
Lee
L
Dixon
W G
WG
Hyrich
K L
KL
Patterson
John R
JR
Symmons
D P M
DP
Toporcer
Mary
M
Mastrangelo
Michael J
MJ
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology / Q000473:pathology; D008545:Melanoma / Q000473:pathology; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000209:etiology*; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors*; D012306:Risk; D012878:Skin Neoplasms / Q000473:pathology
D018501:Antirheumatic Agents; D018124:Receptors, Tumor Necrosis Factor